Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. META
10. TLT

Go back to Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance
(NASDAQ: AUTL) Delayed: 1.92 +0.05 (2.67%)
Previous Close $1.87    52 Week High $ 
Open $1.92    52 Week Low $ 
Day High $1.95    P/E N/A 
Day Low $1.89    EPS $ 
Volume 1,090,995